Long‑read sequencing PacBio’s Revio HiFi sequencing platform and new SPRQ-Nx chemistry indicate a strong opportunity to upsell high‑fidelity long‑read capabilities to pharma, academia, and translational research groups seeking accurate genome, transcriptome, and epigenome analyses.

FFPE workflow The launch of robust HiFi sequencing for FFPE tumor samples opens a path to clinical research and pathology labs exploring archival cancer tissues, enabling sale of sample prep workflows, validated pipelines, and companion analytics.

Tertiary analytics Partnerships like Lucid Genomics and broader compatible software ecosystems suggest a market for integrated bioinformatics solutions and data analysis services that leverage PacBio long‑read data for clinical genomics and precision medicine.

Strategic collaborations Recent collaborations including Anthropic and NVIDIA for large‑scale genome initiatives signal opportunities to offer enterprise data processing, cloud‑based analytics, and compute partnerships to researchers pursuing large population or atlas projects.

Global expansion Worldwide shipping and multi‑country sequencing initiatives imply potential for regional sales expansion, regional support packages, and localized service offerings to accelerate adoption in diverse markets and research institutions.